Neuropsychological features in RASopathies: A pilot study on parent training program involving families of children with Noonan syndrome.
Noonan syndrome
attention deficit hyperactivity disorder
challenging behaviors
evaluation program
parent training
parenting stress
rare disease
Journal
American journal of medical genetics. Part C, Seminars in medical genetics
ISSN: 1552-4876
Titre abrégé: Am J Med Genet C Semin Med Genet
Pays: United States
ID NLM: 101235745
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
25
11
2022
received:
29
07
2022
accepted:
28
11
2022
pubmed:
10
12
2022
medline:
10
1
2023
entrez:
9
12
2022
Statut:
ppublish
Résumé
Noonan syndrome (NS) is a clinical variable multisystem disorder caused by mutations in genes encoding proteins involved in the RAS/mitogen-activated protein kinase signaling pathway. NS is characterized by a distinctive facies, short stature, and congenital heart defects. Psychomotor delay, learning difficulties, and social deficits are also common. Furthermore, behavioral and attention problems can be reckoned as a key symptom in NS, with functioning resembling the patterns observed in attention deficit hyperactivity disorder (ADHD). The complex behavioral phenotype has great impact on the quality of life and raises demanding management issues also for patients' families. Parent management training (PMT) is recommended as first-line treatment for ADHD; however, no study has been performed to test the efficacy of PMT in NS, thus far. The aim of this pilot study is the implementation and evaluation of a PMT dedicated to NS families. Parents of seven children with NS were recruited and underwent to a 10-session PMT. Three different questionnaires were administered to both parents: Conners Parent Rating Scales, Parenting Stress Index Short Form (PSI-SF), and Alabama Parenting Questionnaire (APQ). Our findings on this first small cohort of families indicate that positive perception and satisfaction about the child and the interaction with him increased in mothers after the intervention, as measured respectively by PSI-SF difficult child (DC) and PSI-SF parent-child dysfunctional interaction (PCDI), while mothers' level of stress decreased after the PMT, as indicated by PSI-SF total scores. Furthermore, APQ positive parenting, which measures behaviors of positive relationship with the child, increased in mothers after the intervention. Statistical analysis on fathers' questionnaires did not show significant differences after the PMT sessions. This pilot study suggests that PMT is a promising intervention for parents of NS children with behavioral and ADHD symptoms. Changes in mothers' attitudes and distress indicate that behaviorally oriented programs may help parents to manage with NS phenotype.
Identifiants
pubmed: 36490374
doi: 10.1002/ajmg.c.32025
pmc: PMC10107825
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
510-519Informations de copyright
© 2022 The Authors. American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals LLC.
Références
J Dev Behav Pediatr. 2022 Feb-Mar 01;43(2):e87-e93
pubmed: 34269737
J Adv Nurs. 1993 Jan;18(1):46-53
pubmed: 8429167
Am J Med Genet C Semin Med Genet. 2022 Dec;190(4):510-519
pubmed: 36490374
Cell. 2008 Oct 31;135(3):549-60
pubmed: 18984165
J Clin Psychol Med Settings. 2020 Jun;27(2):256-267
pubmed: 31560100
Eur J Paediatr Neurol. 2018 Jan;22(1):170-177
pubmed: 29037749
Iran J Nurs Midwifery Res. 2015 Jan-Feb;20(1):93-8
pubmed: 25709697
Genet Couns. 2004;15(1):47-52
pubmed: 15083699
Horm Res. 2009 Dec;72 Suppl 2:15-23
pubmed: 20029232
Dev Med Child Neurol. 2017 May;59(5):544-549
pubmed: 28160302
BMC Med. 2012 Sep 04;10:99
pubmed: 22947230
Am J Med Genet A. 2009 Feb;149A(2):140-6
pubmed: 19133693
Pediatrics. 2019 Oct;144(4):
pubmed: 31570648
J Pediatr Psychol. 2003 Apr-May;28(3):197-201
pubmed: 12654945
Orphanet J Rare Dis. 2007 Jan 14;2:4
pubmed: 17222357
Infant Ment Health J. 2017 Mar;38(2):249-257
pubmed: 28236357
J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):835-47, 847.e1-5
pubmed: 25062591
Am J Med Genet A. 2020 Apr;182(4):866-876
pubmed: 31913576
Neuropsychol Rev. 2007 Mar;17(1):5-38
pubmed: 17318413
Pediatrics. 2011 Nov;128(5):1007-22
pubmed: 22003063
Actas Esp Psiquiatr. 2008 Sep-Oct;36(5):285-94
pubmed: 18830848
Am J Hum Genet. 2021 Nov 4;108(11):2112-2129
pubmed: 34626534
Dis Model Mech. 2022 Feb 1;15(2):
pubmed: 35178568
Acta Med Iran. 2016 Aug;54(8):503-509
pubmed: 27701720
Front Behav Neurosci. 2011 Nov 24;5:79
pubmed: 22131969
Brain Sci. 2021 Feb 13;11(2):
pubmed: 33668418
Am J Med Genet A. 2020 Jan;182(1):130-136
pubmed: 31680412
J Atten Disord. 2020 Mar;24(5):758-767
pubmed: 31046533
Dev Med Child Neurol. 2005 Jan;47(1):35-8
pubmed: 15686287
Pediatr Clin North Am. 1978 Nov;25(4):797-816
pubmed: 153516
Am J Med Genet A. 2022 Jun;188(6):1915-1927
pubmed: 35266292
Am J Med Genet A. 2014 Apr;164A(4):934-42
pubmed: 24458522
Clin Psychol Rev. 2006 Jan;26(1):86-104
pubmed: 16280191
Brain Sci. 2019 Jan 23;9(2):
pubmed: 30678024
Lancet Psychiatry. 2016 Jun;3(6):555-67
pubmed: 27183902
J Neurodev Disord. 2017 Jul 10;9:25
pubmed: 28694877
Am J Med Genet A. 2016 Aug;170(8):1974-88
pubmed: 27149079
J Intellect Disabil Res. 2010 Mar;54(3):266-80
pubmed: 20146741
Psychol Med. 2012 Feb;42(2):419-26
pubmed: 21740625
Lancet. 2013 Jan 26;381(9863):333-42
pubmed: 23312968
J Autism Dev Disord. 2011 Jun;41(6):783-95
pubmed: 20859670
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003018
pubmed: 22161373
BMJ Open. 2020 Nov 27;10(11):e037749
pubmed: 33247007
Genet Med. 2018 Oct;20(10):1175-1185
pubmed: 29469822
Annu Rev Genomics Hum Genet. 2013;14:355-69
pubmed: 23875798
Ann N Y Acad Sci. 2010 Dec;1214:99-121
pubmed: 20958325
J Adv Nurs. 2002 Jun;38(6):598-606
pubmed: 12067399
J Adv Nurs. 2001 Nov;36(4):600-7
pubmed: 11703555
Blood. 2005 Sep 15;106(6):2183-5
pubmed: 15928039
Pediatrics. 2010 Oct;126(4):746-59
pubmed: 20876176